BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8850428)

  • 1. Probable risk of tumour induction after retro-orbital irradiation for Graves' ophthalmopathy.
    Snijders-Keilholz A; De Keizer RJ; Goslings BM; Van Dam EW; Jansen JT; Broerse JJ
    Radiother Oncol; 1996 Jan; 38(1):69-71. PubMed ID: 8850428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of a carcinogenic risk for treatment of Graves' ophthalmopathy in dependence on age and irradiation geometry.
    Broerse JJ; Snijders-Keilholz A; Jansen JT; Zoetelief J; Klein C; Seegenschmiedt MH
    Radiother Oncol; 1999 Dec; 53(3):205-8. PubMed ID: 10660199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probable risk of tumor induction after retro-orbital irradiation for Graves' ophthalmopathy.
    Blank LE; Barendsen GW; Prummel MF; Stalpers L; Wiersinga W; Koornneel L
    Radiother Oncol; 1996 Aug; 40(2):187-9. PubMed ID: 8884975
    [No Abstract]   [Full Text] [Related]  

  • 4. High voltage orbital radiotherapy and surgical orbital decompression in the management of Graves' ophthalmopathy.
    Pigeon P; Orgiazzi J; Berthezene F; Gerard JP; Haguenauer JP; Mornex R
    Horm Res; 1987; 26(1-4):172-6. PubMed ID: 3110042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of radiation-induced carcinogenesis after external beam radiotherapy of Graves' orbitopathy.
    Akmansu M; Dirican B; Bora H; Gurel O
    Ophthalmic Res; 2003; 35(3):150-3. PubMed ID: 12711842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy.
    Prummel MF; Mourits MP; Blank L; Berghout A; Koornneef L; Wiersinga WM
    Lancet; 1993 Oct; 342(8877):949-54. PubMed ID: 8105213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy.
    Prummel MF; Terwee CB; Gerding MN; Baldeschi L; Mourits MP; Blank L; Dekker FW; Wiersinga WM
    J Clin Endocrinol Metab; 2004 Jan; 89(1):15-20. PubMed ID: 14715820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orbital irradiation in the treatment of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Panicucci M; Bogazzi F; Pinchera A
    Bull Soc Belge Ophtalmol; 1988; 226():71-83. PubMed ID: 3151769
    [No Abstract]   [Full Text] [Related]  

  • 9. A long-term follow-up study after retro-orbital irradiation for Graves' ophthalmopathy.
    Schaefer U; Hesselmann S; Micke O; Schueller P; Bruns F; Palma C; Willich N
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):192-7. PubMed ID: 11777638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of radiation therapy in Graves' ophthalmopathy.
    Chowdhury AD; Moriarty MJ
    Australas Radiol; 1996 Nov; 40(4):422-3. PubMed ID: 8996904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study.
    Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Lepri A; Pinchera A
    J Endocrinol Invest; 1991 Nov; 14(10):853-60. PubMed ID: 1802923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orbital radiotherapy for Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Pinchera A
    J Clin Endocrinol Metab; 2004 Jan; 89(1):13-4. PubMed ID: 14715819
    [No Abstract]   [Full Text] [Related]  

  • 13. Orbital irradiation for Graves' ophthalmopathy: Is it safe? A long-term follow-up study.
    Wakelkamp IM; Tan H; Saeed P; Schlingemann RO; Verbraak FD; Blank LE; Prummel MF; Wiersinga WM
    Ophthalmology; 2004 Aug; 111(8):1557-62. PubMed ID: 15288988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of developing radiogenic cancer following photon-beam radiotherapy for Graves' orbitopathy.
    Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
    Med Phys; 2018 Oct; 45(10):4775-4782. PubMed ID: 30105825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of supervoltage orbital irradiation for Graves' ophthalmopathy.
    Teng CS; Crombie AL; Hall R; Ross WM
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):545-51. PubMed ID: 6784979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orbital cobalt radiotherapy and systemic or retrobulbar corticosteroids for Graves' ophthalmopathy.
    Pinchera A; Marcocci C; Bartalena L; Panicucci M; Marconcini C; Lepri A; Cavallacci G; Cartei F; Laddaga M
    Horm Res; 1987; 26(1-4):177-83. PubMed ID: 3596466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of radiotherapy for Graves' ophthalmopathy.
    Konishi J; Iida Y; Kasagi K; Misaki T; Arai K; Endo K; Amemiya T; Abe M; Torizuka K
    Endocrinol Jpn; 1986 Oct; 33(5):637-44. PubMed ID: 3830071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orbital radiotherapy for Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Tanda ML; Rocchi R; Mazzi B; Barbesino G; Pinchera A
    Thyroid; 2002 Mar; 12(3):245-50. PubMed ID: 11952048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation retinopathy after orbital irradiation for Graves' ophthalmopathy.
    Kinyoun JL; Kalina RE; Brower SA; Mills RP; Johnson RH
    Arch Ophthalmol; 1984 Oct; 102(10):1473-6. PubMed ID: 6548374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of Graves' ophthalmopathy with irradiation].
    Slampa P; Spurný V; Seneklová Z; Krákorová D
    Vnitr Lek; 1998 Aug; 44(8):461-3. PubMed ID: 10358449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.